Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework

基因分型 病毒学 医学 基因型 生物 遗传学 基因
作者
Lan Xu,Elizaveta Padalko,Anja Oštrbenk,Mario Poljak,Marc Arbyn
出处
期刊:International Journal of Molecular Sciences [Multidisciplinary Digital Publishing Institute]
卷期号:19 (9): 2704-2704 被引量:30
标识
DOI:10.3390/ijms19092704
摘要

In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping Extra II (INNO-LiPA) within the VALGENT-3 framework. VALGENT is designed to assess the analytical and clinical performance of HPV tests with genotyping capacity. The VALGENT-3 panel comprised 1300 consecutive cervical cell specimens enriched with 300 samples with abnormal cytology obtained from women attending the Slovenian cervical cancer screening programme. The INNO-LiPA allows type-specific detection of 32 HPV types; however, for the clinical accuracy assessment, we considered it as high-risk (hr)HPV positive when at least one of the following HPV types was present: HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, and HPV68. Clinical accuracy for detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) was compared between INNO-LiPA and Hybrid Capture 2 (HC2), which is a standard comparator test for HPV tests used in cervical cancer screening. In addition, hrHPV and type-specific detection HPV types were compared between INNO-LiPA and Linear Array HPV Genotyping Test (Linear Array). The prevalence of hrHPV determined by INNO-LiPA was 17.1% (95% CI, 15.0–19.2%) in the screening population. HrHPV testing with INNO-LiPA had a sensitivity for CIN2+ of 96.9% (95% CI, 92.1–99.1%) which was non-inferior to HC2 (relative sensitivity of 1.01; 95% CI, 0.97–1.04; pn.inf = 0.0002) and a specificity for ≤CIN1 of 85.3% (95% CI, 83.2–87.3%) which was inferior to HC2 (relative specificity of 0.95; 95% CI, 0.93–0.97; pn.inf = 0.9998). Genotyping agreement between INNO-LiPA and Linear Array was excellent for hrHPV, HPV16, HPV18, HPV35, HPV45, HPV58 and HPV59, but good or fair for other HPV types. To conclude, INNO-LiPA demonstrated non-inferior clinical sensitivity but lower specificity compared to HC2 in addition to excellent concordance compared to Linear Array for hrHPV and some genotypes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
nothing发布了新的文献求助10
刚刚
打打应助科研通管家采纳,获得10
刚刚
大知闲闲完成签到,获得积分10
1秒前
1秒前
麦子应助科研通管家采纳,获得10
1秒前
1秒前
找找完成签到 ,获得积分10
1秒前
1秒前
dydydyd完成签到,获得积分10
1秒前
cara33完成签到,获得积分10
1秒前
深情安青应助科研通管家采纳,获得10
2秒前
2秒前
陈星完成签到,获得积分20
2秒前
虚心可仁完成签到,获得积分20
2秒前
甜美无剑应助科研通管家采纳,获得80
2秒前
2秒前
英俊的铭应助科研通管家采纳,获得10
2秒前
Fizzes完成签到 ,获得积分10
2秒前
Ziyi_Xu完成签到,获得积分10
2秒前
3秒前
fpy完成签到,获得积分10
3秒前
小包子完成签到,获得积分10
3秒前
猪猪hero应助卑微小谢采纳,获得10
3秒前
梓辰发布了新的文献求助10
3秒前
oxfocean完成签到,获得积分10
3秒前
jiang完成签到,获得积分10
3秒前
疯狂的寻绿完成签到,获得积分10
3秒前
4秒前
嘻嘻完成签到,获得积分10
4秒前
4秒前
隐形皮卡丘完成签到 ,获得积分10
5秒前
是锦锦呀完成签到,获得积分10
5秒前
7秒前
桐桐应助tea采纳,获得10
7秒前
7秒前
7秒前
小李发布了新的文献求助10
8秒前
是锦锦呀发布了新的文献求助10
8秒前
Bestronging完成签到,获得积分10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Continuing Syntax 1000
Signals, Systems, and Signal Processing 610
2026 Hospital Accreditation Standards 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6263447
求助须知:如何正确求助?哪些是违规求助? 8085291
关于积分的说明 16894713
捐赠科研通 5333825
什么是DOI,文献DOI怎么找? 2839101
邀请新用户注册赠送积分活动 1816652
关于科研通互助平台的介绍 1670331